TaBlitz
TaBlitz is the only AI-powered 3D tablet development and design platform that leverages advanced deep learning models and USP <1062> standards to predict powder performance and optimize tablet design early in the pharmaceutical and nutraceutical development process. The platform offers formulation analysis, predictive modeling, guided workflows, and custom 3D tablet design, enabling companies to reduce experimental iterations, minimize material waste, and mitigate formulation risks such as capping and sticking. TaBlitz's Design Intelligence Engine, driven by the Tableting Specification Manual (TSM), ensures right-first-time tablet design with real-time edits and seamless collaboration, accelerating drug development timelines, improving manufacturability, and enhancing patient-centric outcomes. The software integrates with vendor workflows to streamline design-to-production communication, positioning TaBlitz as an indispensable tool for pharmaceutical companies aiming for efficient, high-quality tablet development and regulatory alignment.
TaBlitz
TaBlitz is the only AI-powered 3D tablet development and design platform that leverages advanced deep learning models and USP <1062> standards to predict powder performance and optimize tablet design early in the pharmaceutical and nutraceutical development process. The platform offers formulation analysis, predictive modeling, guided workflows, and custom 3D tablet design, enabling companies to reduce experimental iterations, minimize material waste, and mitigate formulation risks such as capping and sticking. TaBlitz's Design Intelligence Engine, driven by the Tableting Specification Manual (TSM), ensures right-first-time tablet design with real-time edits and seamless collaboration, accelerating drug development timelines, improving manufacturability, and enhancing patient-centric outcomes. The software integrates with vendor workflows to streamline design-to-production communication, positioning TaBlitz as an indispensable tool for pharmaceutical companies aiming for efficient, high-quality tablet development and regulatory alignment.